Acquisitive sports marketing specialist Essentially continues to grow fast, having delivered a bumper set of interim results and added ex-test cricketer Alec Stewart’s Arundel Promotions to the fold through acquisition.
Earlier addition Sportseen, a pitch-side advertising business purchased for £9m in April, made only a small contribution as its major revenue period only begins now. Nevertheless in the six months to June, Essentially lifted revenues 240% to £5.9m – including ‘double digit’ organic growth – with profits before tax and exceptionals rising 224% to £749,000 and earnings per share up by 36% to 0.3p.
The figures were much improved by a full contribution from a cricket marketing business acquired last year, where prospects are being boosted by cricket’s new commercial paradigm, including the cash-rich Indian Premier League and Stanford Twenty20. Also benefiting is Essentially's player management arm, the largest in the cricket and rugby worlds, which enjoyed cricketers’ wage inflation of around 10% last year and contributed 20% of interim sales.
In line with the rest of the media sector however, Essentially’s shares have taken a dive over concerns about falling advertising budgets. Chief executive Bart Campbell admits sponsors are being more selective but remains confident that ‘spending will therefore be more targeted on the events that deliver’ – and is happy therefore to have the rights to sell advertising for next summer’s Ashes tour and be commercial agent for the Rugby World Cup Sevens and the Lions tour of South Africa.
Forecast by house broker Cenkos to deliver earnings per share of 1.6p from £3.6m profits this year, Essentially's current rating looks too low.
Save 50% off your first year’s subscription to Growth Company Investor magazine, and gain immediate access to all the recommendations online. Click here.
Market cap: £21.11m
PE Forecast: 6.7
Share price: 10.75p
More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.
Advertisement
VCT Report 2010 uncovers the money available
for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted
company.
Order VCT Report 2010 today using this online form
A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.
is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.
The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).
A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Delcam, the international seller of CAD/CAM software to the engineering, aerospace and healthcare sectors among others, is a cash-generative small-cap seeing recovery in its markets.
Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.
London pub operator The Capital Pub Company is seeing continuing sales growth on the back of a surprisingly resilient market.